| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $406.98K | $88.20K | $137.84K | $1.10M | $304.02K |
| R&D | – | – | – | – | – |
| SG&A | $406.98K | $88.20K | $137.79K | $1.09M | $301.82K |
| Operating Income | -$406.98K | -$88.20K | -$137.84K | -$1.10M | -$304.02K |
| Interest Expense | – | – | – | – | $1.73K |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$293.07K | $52.84K | -$810.84K | -$1.49M | -$350.14K |
| EPS (basic) | 0.0000 | 0.0000 | -0.0100 | -0.0400 | -0.0100 |
| EPS (diluted) | 0.0000 | 0.0000 | -0.0100 | -0.0400 | -0.0100 |
| Shares (diluted) | $166.76M | $39.94M | $39.94M | $36.61M | $36.34M |